1.	Phase IV Study of Epoetin alfa in Women With Stage I, II, or III Breast Cancer and Chemotherapy-Related Anemia. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase IV Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-0011004, ORTHO-PR-00-27-012, ORTHO-PR-01-27-003, NCI-G01-2002, NCT00022386
2.	Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy Phase: Phase IV Type: Supportive care Status: Completed Age: 21 and over Sponsor: NCI, Other Protocol IDs: 04-08-09-04, NCT00245518
3.	Learning Impairments Among Survivors of Childhood Cancer Phase: Phase IV Type: Supportive care Status: Closed Age: 6 to 18 Sponsor: NCI, Other Protocol IDs: MEMFX2, RO1-CA078957, UO1-CA81445, P30-CA2Z1765, NCT00576472
4.	Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation Phase: Phase III, Phase II Type: Supportive care Status: Completed Age: Over 12 Sponsor: NCI, Other Protocol IDs: 1001.00, FHCRC-1001.00, NCI-G01-2008, CDR0000068886, NCT00024037
5.	Phase II/III Randomized Study of Amifostine Followed By Protracted Fractionated Radiotherapy in Patients With Inoperable, Unresectable, or Postoperatively Recurrent Rectal Adenocarcinoma (Summary Last Modified 11/2001) Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Completed Age: 18 to physiologic 74 Sponsor: NCI Protocol IDs: UPCC-00-A-0465, NCI-T87-0232
6.	Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer Phase: Phase III, Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069401, U10CA037420, URCC-U1902, URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742
7.	Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer Phase: Phase III, Phase II Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000592644, RTOG-0537, NCT00656513
8.	Phase III Randomized Study to Evaluate Quality-of-Life Measurement Tools in Patients with Advanced Colorectal Cancer (Summary Last Modified 04/94) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-939251, NCCTG-93-92-51
9.	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Sucralfate to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 05/94) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-929251, NCI-P94-0054
10.	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Nortriptyline to Alleviate Symptoms of CDDP-Induced Peripheral Neuropathy (Summary Last Modified 10/94) Phase: Phase III Type: Supportive care Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: NCCTG-939252, NCI-P94-0057
11.	Phase III Randomized Study of Sucralfate Suspension vs Topical Vitamin E for the Treatment of Chemotherapy-Induced Mucositis Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-1Z93, NCI-P94-0059
12.	Randomized Study of Pentoxifylline and Best Supportive Care vs Best Supportive Care Only for Radiation-Induced Soft Tissue Necrosis in Cancer Patients (Summary Last Modified 06/1999) Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-9407, RTOG 94-07
13.	Talc in Treating Patients With Malignant Pleural Effusion Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000063982, U10CA031946, CLB-9334, E-C9334, NCCTG-C9334, RTOG-9511, CALGB-9334, NCT00002622
14.	Phase III Randomized, Double-Blind Study of Warfarin vs Placebo for Chemoprevention of Thrombosis in Central Venous Access Catheters in Cancer Patients (Summary Last Modified 12/1999) Phase: Phase III Type: Supportive care Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: CCCWFU-97194, NCI-P95-0064
15.	Phase III Randomized, Double-Blind, Placebo-Controlled Study of VIT-E for the Control of Hot Flushes in Menopausal Women with Prior Breast Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-959253, NCI-P95-0065
16.	Phase III Randomized, Double-Blind Study of Liposomal Amphotericin B vs Standard Formulation Amphotericin B for Empiric Treatment of Persistent Febrile Neutropenia Unresponsive to Broad Spectrum Antibacterial Agents (Summary Last Modified 11/95) Phase: Phase III Type: Supportive care Status: Completed Age: 2 to 80 Sponsor: NCI Protocol IDs: NCI-95-C-0131A
17.	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Glutamine to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/97) Phase: Phase III Type: Supportive care Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: NCCTG-959251, NCI-P95-0069
18.	Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 0 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000064664, POG-9404, NCT01230983
19.	Phase III Randomized, Double-Blind, Crossover Study of Coumarin vs Placebo in Women with Postmastectomy Lymphedema (Summary Last Modified 09/96) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-949255, NCI-P96-0071
20.	Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 21 and under Sponsor: NCI, Other Protocol IDs: CDR0000065013, POG-9426, CCG-P9426, NCT00002827
21.	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065093, U10CA037420, URCC-U10994, NCI-C95-0001, URCC-URRSRB-6993, NCI-P96-0073, ECOG-U1099, C95-0001, NCT00002850
22.	Phase III Randomized, Placebo-Controlled Study of Oral Thymidine for the Prevention of Mucositis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/98) Phase: Phase III Type: Supportive care Status: Closed Age: 18 to 90 Sponsor: NCI Protocol IDs: CHNMC-IRB-90014, NCI-V96-1043
23.	Phase III Randomized, Double-Blind Study of Megestrol vs Dronabinol vs Both in Patients with Cancer-Related Anorexia and Cachexia Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-959255, NCI-P96-0075
24.	Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065154, E-8592, NCCTG-942853, NCI-P96-0076, NCT00002872
25.	Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 21 and under Sponsor: NCI, Other Protocol IDs: CDR0000065359, COG-9425, POG-9425, NCT00005578